Biomarker Analysis of Tislelizumab Combined With Chemotherapy for Perioperative Treatment of G/GEJ Adenocarcinoma

RecruitingOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

July 18, 2022

Primary Completion Date

July 18, 2024

Study Completion Date

July 18, 2026

Conditions
Locally Advanced Gastric AdenocarcinomaPD-1
Interventions
OTHER

DNA panel and RNA Sequencing

"Interventions include collecting samples, DNA panel test and full transcriptome sequencing.~Before collecting samples, obtaining written informed consent from patient in advance.~1. Blood cell samples;~2. Paraffin sample of residual tumor tissue of biopsy;~3. Paraffin sample of residual tumor tissue and paracancer tissue after gastrectomy."

Trial Locations (1)

710000

RECRUITING

Xijing Hospital of Digestive Diseases, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER